Eli Lilly

Eli Lilly

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler

Lilly's breast cancer drug succeeds in late-stage study

The drug is already approved to treat other certain forms of breast cancer, but not for reducing the chances of cancer recurring

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler

Eli Lilly starts trial of rheumatoid arthritis drug in Covid-19 patients

FILE PHOTO: The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, US, May 18, 2018. REUTERS/Brendan McDermid

Lilly Covid-19 treatment could be authorized for use as soon as September

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler

Eli Lilly starts human study of potential Covid-19 antibody treatment